This inventor holds 2 USPTO granted patents. Top assignee: Sovereign Pharmaceuticals, LLC. Active years: 2016-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2017
Title: Himanshu Patel: Innovator in Pharmaceutical Dosage Forms
Introduction
Himanshu Patel is a notable inventor based in North Richland Hills, TX (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of dosage forms for hyoscyamine. With a total of 2 patents, Patel's work is focused on improving the efficacy and delivery of medications.
Latest Patents
Patel's latest patents include innovative methods for administering hyoscyamine. One patent describes a pharmaceutical dosage form that alleviates or treats conditions by administering hyoscyamine, which includes at least one immediate release formulation and one controlled release formulation. Another patent outlines a similar pharmaceutical dosage form that comprises two or more different hyoscyamine formulations, ensuring a versatile approach to treatment. These patents highlight his commitment to enhancing patient care through effective medication delivery.
Career Highlights
Himanshu Patel is currently associated with Sovereign Pharmaceuticals, LLC, where he applies his expertise in pharmaceutical development. His work at Sovereign Pharmaceuticals reflects his dedication to advancing medical science and improving therapeutic outcomes for patients.
Collaborations
Patel collaborates with esteemed colleagues such as Viswanathan Srinivasan and Ralph T Brown. These partnerships foster a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical industry.
Conclusion
Himanshu Patel's contributions to pharmaceutical dosage forms demonstrate his innovative spirit and commitment to improving healthcare. His patents and collaborations reflect a dedication to advancing medical treatments and enhancing patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile